More importantly, the study pointed out that the small molecule inhibitor fludarabine can target NAT10 and inhibit the acetylation modification of ACOT7 mRNA, inhibiting the acetylation modification of ACOT7 mRNA and effectively preventing tumor development. Here, ACOT7 is linked to neoplasm.